Telix Pharmaceuticals

TLX · NASDAQ

$9.15−$0.39 (−4.09%)TodayMarket closed · Oct 23, 7:30 PM ET

Prev close $9.54

Latest news

NewsOct 21, 12:13 PM ETAvi Kapoor
Nasdaq Gains 1%; Thermo Fisher Scientific Posts Upbeat Earnings
Press releaseOct 20, 6:10 PM ETGlobe Newswire
Telix Reports Third Quarter 2026 Financial Performance
Press releaseOct 19, 1:30 AM ETGlobe Newswire
Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.
Press releaseOct 9, 7:45 AM ETGlobe Newswire
Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
Press releaseOct 6, 6:30 AM ETGlobe Newswire
First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)
NewsSep 30, 9:38 AM ET
Telix Receives FDA's Fast Track Designation For Its BiPASS Program To Trace Prostate Cancer Prior To Biopsy
NewsSep 21, 12:04 PM ETAvi Kapoor
Crude Oil Down 4%; Intel Shares Move Higher
NewsSep 21, 10:52 AM ETVandana Singh
Telix Makes $1.65 Billion Bet on ITM to Build a Radiopharma Powerhouse
NewsSep 21, 8:54 AM ET
Reported September 20, 2026: 'Australia's Telix Pharma Agrees To Buy Germany's ITM Isotope For About $1.65B'
NewsSep 21, 5:01 AM ETAvi Kapoor
Why Lobo Technologies Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
Press releaseSep 20, 8:55 PM ETGlobe Newswire
Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse
NewsSep 15, 9:53 AM ETAvi Kapoor
Radiant Logistics, Waystar, Forgent Power Solutions And Other Big Stocks Moving Higher On Tuesday
NewsSep 14, 9:50 AM ETVandana Singh
FDA Approves Telix Pharmaceuticals Brain Cancer Imaging Drug
Press releaseSep 14, 6:30 AM ETGlobe Newswire
FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara
Press releaseSep 9, 6:30 AM ETGlobe Newswire
Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference
NewsSep 2, 10:26 AM ETAvi Kapoor
Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday
Press releaseSep 1, 6:18 PM ETGlobe Newswire
Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway
NewsAug 21, 8:06 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
Press releaseAug 19, 8:32 PM ETGlobe Newswire
Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline
Press releaseJun 22, 5:40 PM ETGlobe Newswire
Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions
Press releaseJun 2, 7:00 AM ETGlobe Newswire
Telix and United Imaging Announce Strategic Theranostics Collaboration
Press releaseJun 1, 5:00 PM ETGlobe Newswire
ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026
Press releaseMay 27, 7:00 AM ETGlobe Newswire
Telix to Participate in William Blair Growth Stock and Jefferies Global Healthcare Conferences
Press releaseMay 18, 5:00 PM ETGlobe Newswire
IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing
NewsMay 18, 6:28 AM ETVandana Singh
Why Is Regeneron Stock Sinking Monday?
Press releaseMay 15, 6:30 AM ETGlobe Newswire
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
Press releaseMay 4, 5:00 PM ETGlobe Newswire
New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC
Press releaseApr 30, 5:43 PM ETGlobe Newswire
TLX101-Px (Pixlumi®) MAA Accepted in Europe
Press releaseApr 29, 5:00 PM ETGlobe Newswire
OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer
Press releaseApr 27, 7:27 PM ETGlobe Newswire
Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach
Press releaseApr 21, 4:49 PM ETGlobe Newswire
ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026
Press releaseApr 14, 7:04 PM ETGlobe Newswire
Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma
NewsApr 14, 8:02 AM ETAvi Kapoor
JPMorgan, Allogene Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
NewsApr 13, 8:38 AM ETVandana Singh
Telix Pharma Gains As Regeneron Tie-Up Targets Solid Tumor Programs
Press releaseApr 13, 6:30 AM ETGlobe Newswire
Regeneron and Telix Announce Strategic Radiopharma Collaboration
Press releaseApr 13, 6:30 AM ETGlobe Newswire
Telix and Regeneron Announce Strategic Radiopharma Collaboration
Press releaseApr 9, 6:51 PM ETGlobe Newswire
FDA Accepts NDA for TLX101-Px (Pixclara®)
Press releaseApr 8, 6:44 PM ETGlobe Newswire
Telix Strengthens Board with Additional Director Appointments
NewsApr 7, 1:56 PM ETVandana Singh
Why Is Telix Pharma Stock Soaring Tuesday?
Press releaseApr 6, 7:37 PM ETGlobe Newswire
Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement
Press releaseApr 1, 7:53 PM ETGlobe Newswire
Telix Appoints David Gill as Non-Executive Director
Press releaseMar 15, 5:25 PM ETGlobe Newswire
Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate
Press releaseMar 9, 7:19 PM ETGlobe Newswire
ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives
NewsAug 28, 8:20 AM ETAvi Kapoor
Cooper Companies Posts Downbeat Sales, Joins NetApp, Urban Outfitters, Nvidia And Other Big Stocks Moving Lower In Thursday Pre-Market Session
NewsAug 28, 5:48 AM ETAvi Kapoor
Why Snowflake Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket
NewsJul 23, 8:35 AM ETAvi Kapoor
Texas Instruments, SAP, Enphase Energy And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
NewsJul 23, 5:00 AM ETAvi Kapoor
Why Vicor Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Nasdaq Gains 1%; Thermo Fisher Scientific Posts Upbeat Earnings

Telix Reports Third Quarter 2026 Financial Performance

Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.

Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care

First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)

Telix Receives FDA's Fast Track Designation For Its BiPASS Program To Trace Prostate Cancer Prior To Biopsy

Crude Oil Down 4%; Intel Shares Move Higher

Telix Makes $1.65 Billion Bet on ITM to Build a Radiopharma Powerhouse

Reported September 20, 2026: 'Australia's Telix Pharma Agrees To Buy Germany's ITM Isotope For About $1.65B'

Why Lobo Technologies Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket

Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse

Radiant Logistics, Waystar, Forgent Power Solutions And Other Big Stocks Moving Higher On Tuesday

FDA Approves Telix Pharmaceuticals Brain Cancer Imaging Drug

FDA Approves Telix’s Brain Cancer Imaging Drug Pixclara

Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference

Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday

Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway

12 Health Care Stocks Moving In Friday's Pre-Market Session

Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline

Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives on Future Therapeutic Directions

Telix and United Imaging Announce Strategic Theranostics Collaboration

ProstACT Global Phase 3 (Part 1) Data Presented in Late-Breaking Oral Session at ASCO 2026

Telix to Participate in William Blair Growth Stock and Jefferies Global Healthcare Conferences

IPAX-2 Study of TLX101-Tx in First-line Glioblastoma Completes Enrolment and Confirms Dosing

Why Is Regeneron Stock Sinking Monday?

Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches

New Publication Demonstrates TLX250-Px (Zircaix®) Potential in Diagnosing Kidney Cancers Beyond ccRCC

TLX101-Px (Pixlumi®) MAA Accepted in Europe

OPTIMAL-PSMA Trial of TLX597-Tx Next Generation RLT Presented at IPCS 2026 Highlighting Therapeutic Potential in Prostate Cancer

Educational Webinar: Unlocking the Potential of PSMA Therapy, A Next‑Generation Portfolio Approach

ProstACT Global Phase 3 (Part 1) Selected as Late-Breaking Abstract at ASCO 2026

Telix Doses First Patient in Phase 3 IPAX-BrIGHT Trial of TLX101-Tx for Recurrent Glioblastoma

JPMorgan, Allogene Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Telix Pharma Gains As Regeneron Tie-Up Targets Solid Tumor Programs

Regeneron and Telix Announce Strategic Radiopharma Collaboration

Telix and Regeneron Announce Strategic Radiopharma Collaboration

FDA Accepts NDA for TLX101-Px (Pixclara®)

Telix Strengthens Board with Additional Director Appointments

Why Is Telix Pharma Stock Soaring Tuesday?

Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement

Telix Appoints David Gill as Non-Executive Director

Telix Resubmits NDA to U.S. FDA for TLX101-Px (Pixclara®) Brain Cancer Imaging Candidate

ProstACT Global Phase 3 Study (Part 1) Achieves Primary Objectives

Cooper Companies Posts Downbeat Sales, Joins NetApp, Urban Outfitters, Nvidia And Other Big Stocks Moving Lower In Thursday Pre-Market Session

Why Snowflake Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket

Texas Instruments, SAP, Enphase Energy And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Why Vicor Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket